Health
PARP inhibitor, stenoparib inhibits pre- and post-entry processes of SARS-CoV-2 in vitro – News-Medical.Net
A team of researchers from the Northern Arizona University evaluated a new PARP inhibitor, stenoparib, which has recently advanced to Stage II of clinical trials…
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus, originated from Wuhan, China, in late December 2019 and rapidly spread across the globe, progressing into a devastating pandemic. To date, the COVID-19 pandemic has caused 54.3 million infections and over 1.31 million deaths worldwide.
In the absence of a vaccine, COVID-19 can continue to cause significant morbidity and mortality
Coronavirus disease (COVID-19) affects the upper and lower respiratory systems and…
-
Noosa News22 hours agoThis 42-Kilometre Walking Trail on the NSW North Coast Weaves Through Ancient Rainforest, Volcanic Mountains and Spectacular Waterfalls
-
Noosa News24 hours agoGabby Petito died after experiencing domestic violence. Young Aussies are identifying with her story
-
Noosa News21 hours agoQueensland cop cleared by court of stealing watches during anti-gang raid
-
Noosa News22 hours agoAnother power station confirmed offline as political fallout continues amid cultural issues